Skip to content

Dismantling the Components and Dosing of CBT for Co-Occurring Disorders

Dismantling the Components and Dosing of CBT for Co-Occurring Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02161211
Acronym
CBT
Enrollment
300
Registered
2014-06-11
Start date
2014-07-31
Completion date
2020-06-19
Last updated
2023-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CBT Decoupling, CBT Anxiety Reduction, CBT Combined

Keywords

alcohol, anxiety

Brief summary

The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.

Interventions

BEHAVIORALDe-coupling

Six sessions of CBT for anxiety-alcohol de-coupling

BEHAVIORALAnxiety Reduction

Six sessions of CBT for anxiety reduction.

BEHAVIORALCombined

Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* diagnostic and Statistical Manual IV diagnosis of panic disorder, generalized anxiety disorder, and/or social anxiety disorder within the past 30 days; * inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence * alcohol use in the 30 days preceding the study * ability to provide informed consent * minimum of a sixth grade reading level (deemed necessary to complete study materials); * willingness to provide contact information to confirm study follow-up appointments * lives within proximity to the Twin Cities (e.g., within about an hour's drive) for the purpose attending follow-up visits

Exclusion criteria

* lifetime history of psychosis or mania by history * cognitive or physical impairment that precludes study participation * currently and seriously suicidal (i.e., plan and intent)

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants That Relapsed to Drinking at 4 Months4 month follow-upRelapse status will be assessed using categorical relapse status (yes vs. no). Count is of those who relapsed
Number of Drinking Days in 4 Months Post Treatment4-monthsNegative binomial regression with offset for possible drinking days exposure in 4 months post treatment
Number of Standard Drinks Per Drinking Day4 monthsDrinks per drinking day among those who relapsed by 4 months. Standard Drink is defined as 12oz beer, 4ox wine, 3oz fortified wine, 1oz hard liquor

Secondary

MeasureTime frameDescription
Number of Participants Who Met SCID-IV Criteria for Alcohol Dependence at 4 Months4 monthsRelapse to Diagnostic and Statistical Manual (DSM)-IV alcohol dependence criteria based on Structured Clinical Interview for DSM-IV (SCID) at 4 months
Number of Participants Who Relapsed to Hazardous Drinking4 monthsRelapse to hazardous drinking (hazardous drinking is defined as 3 or more per occasion for women or more than 7 drinks per week, 4 or more per occasion for men or more than 14 drinks per week) at 4 months

Countries

United States

Participant flow

Participants by arm

ArmCount
De-coupling
Six sessions of CBT for anxiety-alcohol de-coupling De-coupling: Six sessions of CBT for anxiety-alcohol de-coupling
92
Anxiety Reduction
Six sessions of CBT for anxiety reduction. Anxiety Reduction: Six sessions of CBT for anxiety reduction.
94
Combined
Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each. Combined: Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.
93
Total279

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyDropped1259
Overall StudyLost to Follow-up212721

Baseline characteristics

CharacteristicDe-couplingTotalCombinedAnxiety Reduction
Age, Continuous38.5 years40 years38 years43 years
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants11 Participants6 Participants2 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
4 Participants17 Participants8 Participants5 Participants
Race (NIH/OMB)
More than one race
1 Participants15 Participants8 Participants6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
White
82 Participants234 Participants71 Participants81 Participants
Region of Enrollment
United States
92 participants279 participants93 participants94 participants
Sex: Female, Male
Female
34 Participants105 Participants35 Participants36 Participants
Sex: Female, Male
Male
58 Participants174 Participants58 Participants58 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 921 / 941 / 93
other
Total, other adverse events
0 / 920 / 940 / 93
serious
Total, serious adverse events
0 / 920 / 940 / 93

Outcome results

Primary

Number of Drinking Days in 4 Months Post Treatment

Negative binomial regression with offset for possible drinking days exposure in 4 months post treatment

Time frame: 4-months

ArmMeasureValue (MEAN)Dispersion
De-couplingNumber of Drinking Days in 4 Months Post Treatment8.44 drinking daysStandard Error 1.13
Anxiety ReductionNumber of Drinking Days in 4 Months Post Treatment13.04 drinking daysStandard Error 1.53
CombinedNumber of Drinking Days in 4 Months Post Treatment11.34 drinking daysStandard Error 1.45
p-value: 0.13395% CI: [-0.64, 0.084]Wald Chi-squared
p-value: 0.56295% CI: [-0.24, 0.44]Wald Chi-squared
Primary

Number of Participants That Relapsed to Drinking at 4 Months

Relapse status will be assessed using categorical relapse status (yes vs. no). Count is of those who relapsed

Time frame: 4 month follow-up

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
De-couplingNumber of Participants That Relapsed to Drinking at 4 Months30 Participants
Anxiety ReductionNumber of Participants That Relapsed to Drinking at 4 Months43 Participants
CombinedNumber of Participants That Relapsed to Drinking at 4 Months35 Participants
Comparison: Null hypothesis = no difference in frequency in relapse between groupsp-value: 0.673Chi-squared
Primary

Number of Standard Drinks Per Drinking Day

Drinks per drinking day among those who relapsed by 4 months. Standard Drink is defined as 12oz beer, 4ox wine, 3oz fortified wine, 1oz hard liquor

Time frame: 4 months

ArmMeasureValue (MEAN)Dispersion
De-couplingNumber of Standard Drinks Per Drinking Day17.17 drinks per drinking dayStandard Error 2.5
Anxiety ReductionNumber of Standard Drinks Per Drinking Day17.72 drinks per drinking dayStandard Error 2.08
CombinedNumber of Standard Drinks Per Drinking Day17.67 drinks per drinking dayStandard Error 2.31
p-value: 0.982ANOVA
Secondary

Number of Participants Who Met SCID-IV Criteria for Alcohol Dependence at 4 Months

Relapse to Diagnostic and Statistical Manual (DSM)-IV alcohol dependence criteria based on Structured Clinical Interview for DSM-IV (SCID) at 4 months

Time frame: 4 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
De-couplingNumber of Participants Who Met SCID-IV Criteria for Alcohol Dependence at 4 Months13 Participants
Anxiety ReductionNumber of Participants Who Met SCID-IV Criteria for Alcohol Dependence at 4 Months21 Participants
CombinedNumber of Participants Who Met SCID-IV Criteria for Alcohol Dependence at 4 Months16 Participants
Comparison: Null hypothesis = no difference in proportion between the groupsp-value: 0.685Chi-squared
Secondary

Number of Participants Who Relapsed to Hazardous Drinking

Relapse to hazardous drinking (hazardous drinking is defined as 3 or more per occasion for women or more than 7 drinks per week, 4 or more per occasion for men or more than 14 drinks per week) at 4 months

Time frame: 4 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
De-couplingNumber of Participants Who Relapsed to Hazardous Drinking27 Participants
Anxiety ReductionNumber of Participants Who Relapsed to Hazardous Drinking39 Participants
CombinedNumber of Participants Who Relapsed to Hazardous Drinking34 Participants
Comparison: Null hypothesis = no significant difference in frequency of hazardous drinking between groupsp-value: 0.608Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026